Neil V. Harris
Publications by Year
Research Areas
Cholesterol and Lipid Metabolism, Nitric Oxide and Endothelin Effects, Receptor Mechanisms and Signaling, Pharmacogenetics and Drug Metabolism, Lipoproteins and Cardiovascular Health
Most-Cited Works
- → Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes(2011)71 cited
- → Antifolate and antibacterial activities of 5-substituted 2,4-diaminoquinazolines(1990)43 cited
- → Selective ETAAntagonists. 5. Discovery and Structure−Activity Relationships of Phenoxyphenylacetic Acid Derivatives(2000)40 cited
- → Acyl-CoA: cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT(1992)38 cited
- → Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol(1996)34 cited
- → Identification and optimisation of a series of substituted 5-pyridin-2-yl-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors(2006)33 cited
- → Identification and optimisation of a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors(2006)30 cited
- → RP 70676: A potent systematically available inhibitor of acyl-CoA:cholesterol O-acyl transferase (ACAT)(1992)27 cited
- → Selective Endothelin A Receptor Antagonists. 3. Discovery and Structure−Activity Relationships of a Series of 4-Phenoxybutanoic Acid Derivatives(1998)23 cited
- → Acyl-CoA:CholesterolO-Acyltransferase (ACAT) Inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as Potent Inhibitors of ACAT(1996)17 cited